Cargando…
MicroRNA in lung cancer—a novel potential way for early diagnosis and therapy
Lung cancer is the most common cause of cancer-related deaths in the world. One of the reasons of poor prognosis and high mortality of lung cancer patients is the diagnosis of the disease in its advanced stage. Despite innovative diagnostic methods and multiple completed and ongoing clinical trials...
Autores principales: | Frydrychowicz, Magdalena, Kuszel, Łukasz, Dworacki, Grzegorz, Budna-Tukan, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457410/ https://www.ncbi.nlm.nih.gov/pubmed/36821071 http://dx.doi.org/10.1007/s13353-023-00750-2 |
Ejemplares similares
-
Osteoarthritis and telomere shortening
por: Kuszel, Lukasz, et al.
Publicado: (2014) -
11p13 deletions can be more frequent than the PAX6 gene point mutations in Polish patients with aniridia
por: Wawrocka, Anna, et al.
Publicado: (2013) -
Identification of microRNA signature in different pediatric brain
tumors
por: Tantawy, Marwa, et al.
Publicado: (2018) -
A new form or a variant of SMD type A4
por: Marik, Ivo, et al.
Publicado: (2012) -
MicroRNA signature in classical Hodgkin lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2021)